Morgan Stanley Maintains Equal-Weight on UDR, Lowers Price Target to $47
Morgan Stanley analyst Richard Hill maintains UDR (NYSE:UDR) with a Equal-Weight and lowers the price target from $51 to $47.
Morgan Stanley Maintains Equal-Weight on Tricon Residential, Lowers Price Target to $11.75
Morgan Stanley analyst Richard Hill maintains Tricon Residential (NYSE:TCN) with a Equal-Weight and lowers the price target from $13.5 to $11.75.
Morgan Stanley Maintains Overweight on Treace Medical Concepts, Lowers Price Target to $22
Morgan Stanley analyst Drew Ranieri maintains Treace Medical Concepts (NASDAQ:TMCI) with a Overweight and lowers the price target from $26 to $22.
Morgan Stanley Maintains Overweight on Trane Technologies, Lowers Price Target to $153
Morgan Stanley analyst Joshua Pokrzywinski maintains Trane Technologies (NYSE:TT) with a Overweight and lowers the price target from $155 to $153.
Morgan Stanley Maintains Equal-Weight on Teleflex, Lowers Price Target to $300
Morgan Stanley analyst Drew Ranieri maintains Teleflex (NYSE:TFX) with a Equal-Weight and lowers the price target from $343 to $300.
Morgan Stanley Maintains Equal-Weight on Stryker, Lowers Price Target to $220
Morgan Stanley analyst Cecilia Furlong maintains Stryker (NYSE:SYK) with a Equal-Weight and lowers the price target from $270 to $220.
Raymond James Cuts Forward Air Price Target By 7%
Raymond James analyst Patrick Tyler Brown lowered the price target for Forward Air Corp (NASDAQ:FWRD) to $135 (an upside of 50%) from $145…
Morgan Stanley Maintains Overweight on Stanley Black & Decker, Lowers Price Target to $130
Morgan Stanley analyst Joshua Pokrzywinski maintains Stanley Black & Decker (NYSE:SWK) with a Overweight and lowers the price target from $137 to $130.
Morgan Stanley Maintains Overweight on Simon Property Group, Lowers Price Target to $133
Morgan Stanley analyst Richard Hill maintains Simon Property Group (NYSE:SPG) with a Overweight and lowers the price target from $145 to $133.
Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18
Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $22 to $18.